Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06982066 · ClinicalTrials.gov registry record · NA
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
A NA study of Pediatric Cancer and Adolescent and Young Adult Cancer, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06982066: Recruiting NA study of Pediatric Cancer and Adolescent and Young Adult Cancer, sponsored by Connecticut Children's Medical Center.
NCT06982066 is a NA study of Pediatric Cancer and Adolescent and Young Adult Cancer that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 60 participants, below the 1,489-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06982066, a NA study of Pediatric Cancer and Adolescent and Young Adult Cancer, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.
Primary Outcome
Feasibility will be based on patient recruitment and completion of the intervention. The intervention will be considered feasible if AYA recruitment is greater than or equal to 60% and if greater than or equal to 80% of consented AYAs complete the intervention (retention). Intervention completion will be defined as AYA completion of the pre-visit questionnaire and post-intervention survey.
Conditions Studied
Interventions
- BEHAVIORAL ReSPECT
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-02-10 |
| Est. Completion | 2029-06-29 |
| Phase | NA |
What NCT06982066 shows while recruiting
NCT06982066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,489-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which ReSPECT is the first listed.
NCT06982066 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06982066 about?
NCT06982066 is a clinical study titled "Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention". The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication...
What is the current status of trial NCT06982066?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-10. Estimated completion is 2029-06-29.
What conditions does trial NCT06982066 study?
This clinical trial studies the following conditions: Pediatric Cancer, Adolescent and Young Adult Cancer.
What interventions are being tested in trial NCT06982066?
The interventions under investigation include: ReSPECT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06982066?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06982066 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06982066's enrollment target sits among peer trials
60 26th of 51 higher than 24 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
-
Medically Tailored Meals for Kids
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI